Cellectis Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 Nov 23 | Buy€74,480,000 | AstraZeneca PLC | Company | 16,000,000 | €4.66 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,446,061 | 2.02% |
Private Companies | 2,509,157 | 3.5% |
VC/PE Firms | 5,873,247 | 8.19% |
Institutions | 13,477,553 | 18.8% |
Public Companies | 18,786,924 | 26.2% |
General Public | 29,658,259 | 41.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
16,000,000 | €38.1m | 0% | no data | |||
5,873,247 | €14.0m | 0% | 0.08% | |||
4,487,293 | €10.7m | -37.4% | 1.47% | |||
2,786,924 | €6.6m | 0% | no data | |||
2,609,801 | €6.2m | 0% | no data | |||
2,164,613 | €5.2m | -49.8% | no data | |||
1,743,678 | €4.1m | 0% | no data | |||
1,438,255 | €3.4m | 0% | no data | |||
1,039,906 | €2.5m | 87.6% | 0.03% | |||
996,034 | €2.4m | 0% | no data | |||
745,360 | €1.8m | 3.46% | no data | |||
703,041 | €1.7m | 0% | no data | |||
369,620 | €879.7k | -34% | no data | |||
326,894 | €778.0k | 100% | no data | |||
279,994 | €666.4k | 0% | no data | |||
226,875 | €540.0k | 0% | no data | |||
206,071 | €490.4k | 0% | 0.03% | |||
183,011 | €435.6k | 0% | no data | |||
133,143 | €316.9k | 9.65% | no data | |||
126,342 | €300.7k | 0% | 0.06% | |||
116,754 | €277.9k | -12.8% | no data | |||
85,000 | €202.3k | 0% | 0.02% | |||
76,225 | €181.4k | 12.8% | no data | |||
72,187 | €171.8k | 13.4% | no data | |||
71,638 | €170.5k | 0% | no data |